氯硝西泮

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • 结构与计算化学

氯硝西泮 基本信息

中文名称:
氯硝西泮 
中文别名:
氯安定;
氯硝西泮;
5-(邻氯苯基)-1,3-二氢-7-硝基-2H-1,4-苯并二氮杂草-2-酮;
5-(2-氯苯基)-1,3-二氢-7-硝基-2H-1,4-苯并二氮杂卓-2-酮 
英文名称:
clonazepam
英文别名:
clonazepam;
Sentil;
ro5-4023;
Ribotril;
Clonopin;
Rivotril;
Rivotri;
ro4-8180;
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one;
RO4023;
Landsen;
Clonazepam;
Klonopin 
CAS No.:
1622-61-3
分 子 式:
C15H10ClN3O3
分 子 量:
315.71100
精确分子量:
315.04100
PSA:
87.28000
MDL:
MFCD00057746
EINECS:
216-596-2
InChI:
InChI=1/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)
风险术语:
11-23/24/25-39/23/24/25
分子结构式:
SDS:
查看

氯硝西泮 制备方法及用途

制备方法

2-氨基-2'硝基二苯酮用亚硝酸钠重氮化、氯化亚铜置换得到2-氯-2'-硝基二苯酮,催化加氢得2-氨基-2'-氯二苯酮,与溴乙酰溴反应生成2-溴-2'(2-氯苯甲酰)乙酰苯胺,将其与吡啶一起回流24h,生成5-(2-氯苯基)-3H-1,4-苯并二氮杂草-2(1H)-酮,最后硝化为氯硝安定。

合成制备方法

2-氨基-2'硝基二苯酮用亚硝酸钠重氮化、氯化亚铜置换得到2--2'-硝基二苯酮,催化加氢得2-氨基-2'-氯二苯酮,与溴乙酰溴反应生成2--2'2-氯苯甲酰)乙酰苯胺,将其与吡啶一起回流24h,生成5-2-氯苯基)-3H-14-苯并二氮杂草-21H-酮,最后硝化为氯硝安定。

用途简介

抗惊厥药。抗惊厥作用比地西泮或硝西泮约强5倍。适用于控制和型癫痫,对失神小发作,婴儿痉挛、肌阵挛性和运动不能性发作疗效较好。为广谱抗癫痫药

用途

抗惊厥药。抗惊厥作用比地西泮或硝西泮约强5倍。适用于控制和型癫痫,对失神小发作,婴儿痉挛、肌阵挛性和运动不能性发作疗效较好。为广谱抗癫痫药

 

氯硝西泮 物化性质

外观与性状:
类白色结晶性粉末。熔点236.5-238.5。溶于水,易溶于甲醇、乙醚、苯。
密度:
1.5g/cm3
熔点:
236.5-238.50C
沸点:
524.5°C at 760 mmHg
闪点:
11 °C
存储条件/存储方法:
2-8°C
稳定性相关:

 常温常压下稳定,避免氧化物 酸性氯化物 醋酸酐 碱金属 还原剂接触

其它信息:

1.       性状:,类白色结晶性粉末。

2.       密度(g/mL,25/4): 未确定

3.       相对蒸汽密度(g/mL,空气=1):未确定

4.       熔点(ºC):236.5-238.5

5.       沸点(ºC,常压):未确定

6.       沸点(ºC,5.2kPa): 未确定

7.       折射率: 未确定

8.       闪点(ºC): 11

9.       比旋光度(º): 未确定

10.    自燃点或引燃温度(ºC): 未确定

11.    蒸气压(kPa,25ºC): 未确定

12.    饱和蒸气压(kPa,60ºC): 未确定

13.    燃烧热(KJ/mol):未确定

14.    临界温度(ºC): 未确定

15.    临界压力(KPa): 未确定

16.    油水(辛醇/水)分配系数的对数值: 未确定

17.    爆炸上限(%,V/V):未确定

18.    爆炸下限(%,V/V): 未确定

19.    溶解性:溶于水,易溶于甲醇、乙醚、苯。

氯硝西泮 安全信息

包装等级:
III
风险类别:
6.1(b)
WGK_Germany:
2
德国有关水污染物质的分类清单
危险类别码:
R11:Highly Flammable. R23/24/25:Toxic by inhalation, in contact with skin and if swallowed . R39/23/24/25:Toxic: danger of very serious irreversible effects through inhalation, in contact with skin and if swallowed .
安全说明:
S7-S16-S36/37-S45-S24/25-S22
RTECS号:
DF2100000
危险标志:
F,T

氯硝西泮 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DF2100000
CHEMICAL NAME :
2-H-1,4-Benzodiazepin-2-one, 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-
CAS REGISTRY NUMBER :
1622-61-3
BEILSTEIN REFERENCE NO. :
0759557
LAST UPDATED :
199706
DATA ITEMS CITED :
16
MOLECULAR FORMULA :
C15-H10-Cl-N3-O3
MOLECULAR WEIGHT :
315.73
WISWESSER LINE NOTATION :
T67 GMV JN IHJ CNW KR BG

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
21 mg/kg/26W-I
TOXIC EFFECTS :
Peripheral Nerve and Sensation - fasciculations
REFERENCE :
PGMJAO Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1925- Volume(issue)/page/year: 63,311,1987
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
1329 ug/kg/31D-I
TOXIC EFFECTS :
Liver - liver function tests impaired
REFERENCE :
AJGAAR American Journal of Gastroenterology. (American College of Gastroenterology, Inc., 428 E. Preston St., Baltimore, MD 21202) V.21- 1954- Volume(issue)/page/year: 83,576,1988
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>15 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,235,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
14200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 11,811,1980
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,235,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PJPPAA Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25- 1973- Volume(issue)/page/year: 35,77,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
13300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 11,811,1980
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,235,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 11,811,1980 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
7280 mg/kg/26W-I
TOXIC EFFECTS :
Brain and Coverings - changes in brain weight Kidney, Ureter, Bladder - changes in bladder weight Endocrine - changes in thyroid weight
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 4,1441,1976 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
1750 ug/kg
SEX/DURATION :
female 14-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - biochemical and metabolic
REFERENCE :
LIFSAK Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69; V.14- 1974- Volume(issue)/page/year: 44,493,1989
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3300 ug/kg
SEX/DURATION :
female 6-16 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 40,365,1977
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
8 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
DGDFA5 Development, Growth & Differentiation. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.11- 1969- Volume(issue)/page/year: 22,61,1980
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
24 mg/kg
SEX/DURATION :
female 6-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 5,2457,1977 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5401 No. of Facilities: 46 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 998 (estimated) No. of Female Employees: 546 (estimated)
毒理学数据:

对眼睛、皮肤、粘膜有刺激作用

氯硝西泮 分子结构与计算化学数据

分子结构数据

1、   摩尔折射率:81.24

2、   摩尔体积(m3/mol):209.9

3、   等张比容(90.2K):588.6

4、   表面张力(dyne/cm):61.8

5、   介电常数(F/m):无可用

6、   极化率10-24cm3):32.20

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:4

4.可旋转化学键数量:1

5.互变异构体数量:10

6.拓扑分子极性表面积87.3

7.重原子数量:22

8.表面电荷:0

9.复杂度:491

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

推荐供应商更多供应商>>